| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Tretinoin | 1 | 2021 | 99 | 0.86 | Why? |
| Silver | 2 | 2021 | 327 | 0.84 | Why? |
| Polyomavirus | 1 | 2018 | 37 | 0.76 | Why? |
| Capsid Proteins | 2 | 2018 | 365 | 0.74 | Why? |
| Pregnenediones | 1 | 2020 | 182 | 0.71 | Why? |
| Adenomatous Polyposis Coli Protein | 1 | 2017 | 15 | 0.69 | Why? |
| Tumor Virus Infections | 1 | 2018 | 127 | 0.69 | Why? |
| Polyomavirus Infections | 1 | 2018 | 156 | 0.66 | Why? |
| gag Gene Products, Human Immunodeficiency Virus | 1 | 2017 | 95 | 0.63 | Why? |
| Endoribonucleases | 1 | 2020 | 407 | 0.60 | Why? |
| Hepatitis B virus | 5 | 2018 | 882 | 0.52 | Why? |
| Metal Nanoparticles | 1 | 2020 | 771 | 0.50 | Why? |
| Epitopes | 3 | 2021 | 4113 | 0.46 | Why? |
| Immunomodulation | 1 | 2021 | 1472 | 0.45 | Why? |
| Biosensing Techniques | 2 | 2022 | 2116 | 0.42 | Why? |
| Antibodies, Monoclonal | 2 | 2021 | 8041 | 0.42 | Why? |
| Acquired Immunodeficiency Syndrome | 1 | 2017 | 533 | 0.42 | Why? |
| Respiratory Syncytial Virus, Human | 1 | 2017 | 846 | 0.40 | Why? |
| Antiviral Agents | 6 | 2021 | 41703 | 0.37 | Why? |
| Organic Anion Transporters, Sodium-Dependent | 2 | 2018 | 26 | 0.37 | Why? |
| Neoplastic Stem Cells | 3 | 2019 | 120 | 0.36 | Why? |
| Symporters | 2 | 2018 | 80 | 0.35 | Why? |
| Respirovirus Infections | 2 | 2018 | 90 | 0.33 | Why? |
| Neutralization Tests | 1 | 2020 | 6698 | 0.33 | Why? |
| Virus Replication | 4 | 2021 | 14331 | 0.29 | Why? |
| Immunoassay | 1 | 2021 | 4485 | 0.29 | Why? |
| Antibodies, Viral | 4 | 2022 | 51949 | 0.29 | Why? |
| Viral Envelope Proteins | 1 | 2017 | 3539 | 0.28 | Why? |
| Glucocorticoids | 1 | 2020 | 4431 | 0.27 | Why? |
| Antibodies, Neutralizing | 2 | 2022 | 25288 | 0.27 | Why? |
| Virus Assembly | 2 | 2017 | 438 | 0.27 | Why? |
| Time-to-Treatment | 1 | 2021 | 5883 | 0.26 | Why? |
| Host-Pathogen Interactions | 3 | 2018 | 11041 | 0.24 | Why? |
| Viral Nonstructural Proteins | 1 | 2020 | 4810 | 0.24 | Why? |
| Immunosuppressive Agents | 1 | 2021 | 6331 | 0.24 | Why? |
| Immunologic Techniques | 1 | 2022 | 71 | 0.23 | Why? |
| Cell Line, Tumor | 3 | 2021 | 3608 | 0.23 | Why? |
| HIV-1 | 1 | 2017 | 3365 | 0.23 | Why? |
| Phosphoproteins | 2 | 2021 | 4346 | 0.21 | Why? |
| High-Throughput Screening Assays | 2 | 2021 | 1783 | 0.21 | Why? |
| Vero Cells | 4 | 2021 | 14117 | 0.21 | Why? |
| Mice, Inbred BALB C | 3 | 2021 | 5814 | 0.21 | Why? |
| Structural Homology, Protein | 1 | 2020 | 149 | 0.20 | Why? |
| Receptors, Tumor Necrosis Factor | 1 | 2019 | 40 | 0.19 | Why? |
| Serine | 1 | 2019 | 90 | 0.19 | Why? |
| Antigen-Antibody Reactions | 1 | 2021 | 616 | 0.19 | Why? |
| Biomarkers, Tumor | 2 | 2019 | 1314 | 0.19 | Why? |
| Hybridomas | 1 | 2018 | 74 | 0.19 | Why? |
| DEAD Box Protein 58 | 1 | 2021 | 250 | 0.19 | Why? |
| Streptolysins | 1 | 2018 | 8 | 0.19 | Why? |
| Polyubiquitin | 1 | 2018 | 14 | 0.19 | Why? |
| Nedd4 Ubiquitin Protein Ligases | 1 | 2018 | 43 | 0.19 | Why? |
| HN Protein | 1 | 2018 | 8 | 0.19 | Why? |
| Influenzavirus C | 1 | 2018 | 37 | 0.19 | Why? |
| Gene Expression | 2 | 2020 | 3332 | 0.19 | Why? |
| rab GTP-Binding Proteins | 1 | 2018 | 59 | 0.18 | Why? |
| Genes, Viral | 3 | 2018 | 1428 | 0.18 | Why? |
| Hand Deformities, Congenital | 1 | 2017 | 3 | 0.18 | Why? |
| Microtubules | 1 | 2017 | 47 | 0.18 | Why? |
| Dimethylpolysiloxanes | 1 | 2017 | 46 | 0.18 | Why? |
| Congenital Hypothyroidism | 1 | 2017 | 5 | 0.17 | Why? |
| Polycomb Repressive Complex 2 | 1 | 2017 | 10 | 0.17 | Why? |
| Mechanotransduction, Cellular | 1 | 2017 | 28 | 0.17 | Why? |
| Respirovirus | 1 | 2018 | 122 | 0.17 | Why? |
| Cullin Proteins | 1 | 2017 | 31 | 0.17 | Why? |
| Pyrans | 1 | 2017 | 56 | 0.17 | Why? |
| Parainfluenza Virus 1, Human | 1 | 2017 | 71 | 0.17 | Why? |
| Hepatitis B | 4 | 2018 | 888 | 0.17 | Why? |
| Viral Fusion Protein Inhibitors | 1 | 2018 | 88 | 0.17 | Why? |
| Cell Survival | 2 | 2020 | 1581 | 0.17 | Why? |
| Enhancer of Zeste Homolog 2 Protein | 1 | 2017 | 40 | 0.17 | Why? |
| Parainfluenza Virus 3, Human | 1 | 2017 | 67 | 0.17 | Why? |
| SARS Virus | 1 | 2021 | 13021 | 0.17 | Why? |
| Receptors, Immunologic | 1 | 2021 | 555 | 0.17 | Why? |
| Craniofacial Abnormalities | 1 | 2017 | 33 | 0.17 | Why? |
| Sesquiterpenes | 1 | 2017 | 77 | 0.17 | Why? |
| Abnormalities, Multiple | 1 | 2017 | 75 | 0.16 | Why? |
| RNA, Viral | 4 | 2021 | 32276 | 0.16 | Why? |
| src-Family Kinases | 1 | 2016 | 48 | 0.16 | Why? |
| Phylogeny | 5 | 2018 | 13341 | 0.16 | Why? |
| Oligopeptides | 1 | 2020 | 576 | 0.16 | Why? |
| Viral Structural Proteins | 1 | 2020 | 491 | 0.16 | Why? |
| Herpesvirus 2, Human | 1 | 2017 | 137 | 0.16 | Why? |
| Precancerous Conditions | 1 | 2017 | 108 | 0.16 | Why? |
| Thermodynamics | 1 | 2020 | 873 | 0.16 | Why? |
| Hepatitis B Surface Antigens | 1 | 2018 | 305 | 0.15 | Why? |
| Protein Structure, Secondary | 1 | 2020 | 1077 | 0.15 | Why? |
| Amino Acid Substitution | 3 | 2018 | 1706 | 0.15 | Why? |
| Animals | 9 | 2021 | 78931 | 0.15 | Why? |
| Interferon Regulatory Factors | 1 | 2016 | 141 | 0.15 | Why? |
| Particle Size | 1 | 2020 | 1052 | 0.14 | Why? |
| Mumps virus | 1 | 2014 | 15 | 0.14 | Why? |
| Breast Neoplasms | 3 | 2018 | 3633 | 0.14 | Why? |
| Markov Chains | 1 | 2017 | 502 | 0.14 | Why? |
| Oncolytic Virotherapy | 1 | 2014 | 36 | 0.14 | Why? |
| Protein Binding | 4 | 2020 | 11430 | 0.14 | Why? |
| Cysteine Proteinase Inhibitors | 1 | 2021 | 675 | 0.14 | Why? |
| Caliciviridae Infections | 1 | 2018 | 229 | 0.14 | Why? |
| Herpesvirus 1, Human | 1 | 2017 | 286 | 0.14 | Why? |
| Immunohistochemistry | 2 | 2018 | 2275 | 0.13 | Why? |
| Herpesvirus 4, Human | 1 | 2017 | 387 | 0.13 | Why? |
| Norovirus | 1 | 2018 | 294 | 0.13 | Why? |
| Lysosomes | 1 | 2017 | 416 | 0.13 | Why? |
| Epitope Mapping | 1 | 2018 | 1240 | 0.13 | Why? |
| Models, Molecular | 2 | 2018 | 7616 | 0.13 | Why? |
| Promoter Regions, Genetic | 1 | 2017 | 823 | 0.13 | Why? |
| DNA, Viral | 3 | 2018 | 2521 | 0.13 | Why? |
| Cell Line | 5 | 2020 | 12040 | 0.13 | Why? |
| Induced Pluripotent Stem Cells | 1 | 2018 | 584 | 0.13 | Why? |
| Humans | 35 | 2022 | 930598 | 0.13 | Why? |
| RNA, Long Noncoding | 1 | 2018 | 408 | 0.13 | Why? |
| Mice | 5 | 2021 | 21357 | 0.12 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.12 | Why? |
| Viral Fusion Proteins | 1 | 2017 | 399 | 0.12 | Why? |
| Gene Expression Regulation, Viral | 1 | 2018 | 925 | 0.12 | Why? |
| Measles virus | 1 | 2014 | 194 | 0.12 | Why? |
| Protein Interaction Domains and Motifs | 1 | 2020 | 2134 | 0.12 | Why? |
| Streptococcus pneumoniae | 1 | 2018 | 827 | 0.12 | Why? |
| Glycosylation | 1 | 2017 | 1255 | 0.12 | Why? |
| Hep G2 Cells | 3 | 2018 | 391 | 0.12 | Why? |
| Sequence Alignment | 1 | 2018 | 2109 | 0.12 | Why? |
| Virion | 1 | 2020 | 1444 | 0.12 | Why? |
| RNA, Small Interfering | 1 | 2017 | 817 | 0.12 | Why? |
| Urinary Bladder Neoplasms | 1 | 2019 | 614 | 0.12 | Why? |
| Antineoplastic Agents | 2 | 2019 | 3550 | 0.12 | Why? |
| Organoids | 1 | 2018 | 840 | 0.11 | Why? |
| Virus Internalization | 3 | 2020 | 7921 | 0.11 | Why? |
| Mitochondria | 1 | 2019 | 857 | 0.11 | Why? |
| Immunization | 1 | 2021 | 2019 | 0.11 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.11 | Why? |
| Iron | 1 | 2017 | 619 | 0.11 | Why? |
| Dose-Response Relationship, Drug | 1 | 2020 | 3776 | 0.11 | Why? |
| Bayes Theorem | 2 | 2018 | 3237 | 0.11 | Why? |
| Autophagy | 1 | 2018 | 960 | 0.11 | Why? |
| Virus Attachment | 1 | 2018 | 1259 | 0.10 | Why? |
| Multiplex Polymerase Chain Reaction | 1 | 2017 | 1439 | 0.09 | Why? |
| Epitopes, B-Lymphocyte | 1 | 2017 | 1267 | 0.09 | Why? |
| Autoimmunity | 1 | 2016 | 841 | 0.09 | Why? |
| Epithelial Cells | 2 | 2018 | 3508 | 0.09 | Why? |
| Nucleocapsid Proteins | 1 | 2021 | 3120 | 0.09 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2020 | 13720 | 0.09 | Why? |
| Drug Screening Assays, Antitumor | 2 | 2019 | 138 | 0.09 | Why? |
| Leukemia, Myeloid, Acute | 1 | 2014 | 676 | 0.09 | Why? |
| Dendritic Cells | 1 | 2016 | 1330 | 0.08 | Why? |
| Exanthema | 1 | 2017 | 1097 | 0.08 | Why? |
| Binding Sites | 1 | 2020 | 6201 | 0.08 | Why? |
| Point-of-Care Systems | 1 | 2021 | 2955 | 0.08 | Why? |
| Molecular Dynamics Simulation | 1 | 2020 | 4155 | 0.08 | Why? |
| Evolution, Molecular | 2 | 2018 | 3691 | 0.08 | Why? |
| Skin | 1 | 2018 | 2096 | 0.08 | Why? |
| Ubiquitination | 2 | 2018 | 343 | 0.08 | Why? |
| Proteomics | 1 | 2017 | 2481 | 0.07 | Why? |
| Lupus Erythematosus, Systemic | 1 | 2016 | 1380 | 0.07 | Why? |
| Japan | 4 | 2021 | 6653 | 0.07 | Why? |
| Antigens, Viral | 1 | 2021 | 6298 | 0.07 | Why? |
| Liver | 1 | 2018 | 4007 | 0.07 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.06 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.06 | Why? |
| Interleukin-6 | 1 | 2021 | 7522 | 0.06 | Why? |
| HEK293 Cells | 1 | 2017 | 8394 | 0.06 | Why? |
| Sensitivity and Specificity | 2 | 2021 | 22971 | 0.06 | Why? |
| Peptidylprolyl Isomerase | 1 | 2002 | 10 | 0.06 | Why? |
| Cyclin D1 | 1 | 2002 | 22 | 0.06 | Why? |
| Immunoglobulin M | 1 | 2020 | 9091 | 0.06 | Why? |
| Disease Progression | 1 | 2021 | 13580 | 0.06 | Why? |
| Cytokines | 2 | 2021 | 15010 | 0.05 | Why? |
| Disease Models, Animal | 1 | 2018 | 10998 | 0.05 | Why? |
| Fever | 1 | 2017 | 7795 | 0.05 | Why? |
| Mutation | 2 | 2017 | 12376 | 0.05 | Why? |
| Retinal Dehydrogenase | 1 | 2018 | 9 | 0.05 | Why? |
| Genome, Viral | 2 | 2018 | 13157 | 0.05 | Why? |
| Coumarins | 1 | 2018 | 46 | 0.05 | Why? |
| Isoenzymes | 1 | 2018 | 127 | 0.04 | Why? |
| Hepatitis D | 1 | 2018 | 48 | 0.04 | Why? |
| Hepatitis Delta Virus | 1 | 2018 | 54 | 0.04 | Why? |
| Tubulin | 1 | 2017 | 67 | 0.04 | Why? |
| Bile Acids and Salts | 1 | 2018 | 91 | 0.04 | Why? |
| Neoplasm Grading | 1 | 2019 | 400 | 0.04 | Why? |
| Actins | 1 | 2017 | 108 | 0.04 | Why? |
| Cell Polarity | 1 | 2017 | 85 | 0.04 | Why? |
| Triple Negative Breast Neoplasms | 1 | 2018 | 92 | 0.04 | Why? |
| MCF-7 Cells | 1 | 2017 | 199 | 0.04 | Why? |
| Phosphorylation | 2 | 2016 | 1060 | 0.04 | Why? |
| DNA Replication | 1 | 2017 | 121 | 0.04 | Why? |
| Cystectomy | 1 | 2019 | 218 | 0.04 | Why? |
| Herpes Genitalis | 1 | 2017 | 90 | 0.04 | Why? |
| Biomarkers | 1 | 2020 | 23361 | 0.04 | Why? |
| Terpenes | 1 | 2017 | 135 | 0.04 | Why? |
| Tubulin Modulators | 1 | 2017 | 126 | 0.04 | Why? |
| Child, Preschool | 5 | 2018 | 36283 | 0.04 | Why? |
| Oxygen Consumption | 1 | 2021 | 711 | 0.04 | Why? |
| Myeloid Differentiation Factor 88 | 1 | 2016 | 109 | 0.04 | Why? |
| Molecular Conformation | 1 | 2017 | 374 | 0.04 | Why? |
| Heterozygote | 1 | 2017 | 249 | 0.04 | Why? |
| Sirolimus | 1 | 2018 | 240 | 0.04 | Why? |
| Middle Aged | 5 | 2022 | 270681 | 0.04 | Why? |
| Methylation | 1 | 2017 | 332 | 0.04 | Why? |
| Immunoglobulin G | 1 | 2020 | 21571 | 0.04 | Why? |
| Respiratory Tract Infections | 1 | 2017 | 6817 | 0.04 | Why? |
| Pedigree | 1 | 2017 | 502 | 0.04 | Why? |
| Transcriptional Activation | 1 | 2016 | 196 | 0.04 | Why? |
| Mice, Knockout | 2 | 2016 | 1815 | 0.04 | Why? |
| Cells, Cultured | 2 | 2017 | 5835 | 0.04 | Why? |
| Young Adult | 3 | 2022 | 93724 | 0.04 | Why? |
| U937 Cells | 1 | 2014 | 77 | 0.04 | Why? |
| Neoplasm Invasiveness | 1 | 2017 | 582 | 0.04 | Why? |
| Infant | 4 | 2018 | 30274 | 0.03 | Why? |
| Glucose | 1 | 2019 | 573 | 0.03 | Why? |
| Female | 11 | 2021 | 380317 | 0.03 | Why? |
| Acute Disease | 2 | 2018 | 6029 | 0.03 | Why? |
| Likelihood Functions | 1 | 2017 | 719 | 0.03 | Why? |
| Jurkat Cells | 1 | 2014 | 273 | 0.03 | Why? |
| Protein Precursors | 1 | 2018 | 425 | 0.03 | Why? |
| Histones | 1 | 2017 | 371 | 0.03 | Why? |
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2018 | 511 | 0.03 | Why? |
| Cloning, Molecular | 1 | 2017 | 1036 | 0.03 | Why? |
| Xenograft Model Antitumor Assays | 1 | 2014 | 274 | 0.03 | Why? |
| Neoplasm Metastasis | 1 | 2017 | 682 | 0.03 | Why? |
| Area Under Curve | 1 | 2021 | 2564 | 0.03 | Why? |
| DNA-Binding Proteins | 1 | 2017 | 469 | 0.03 | Why? |
| Mice, Nude | 1 | 2014 | 340 | 0.03 | Why? |
| Toll-Like Receptors | 1 | 2016 | 365 | 0.03 | Why? |
| Influenza, Human | 1 | 2018 | 10779 | 0.03 | Why? |
| Adult | 6 | 2022 | 244371 | 0.03 | Why? |
| Cell Movement | 1 | 2017 | 695 | 0.03 | Why? |
| Homeostasis | 1 | 2017 | 582 | 0.03 | Why? |
| Epstein-Barr Virus Infections | 1 | 2017 | 366 | 0.03 | Why? |
| Metabolomics | 1 | 2019 | 921 | 0.03 | Why? |
| Gastroenteritis | 1 | 2018 | 489 | 0.03 | Why? |
| DNA Primers | 1 | 2017 | 1170 | 0.03 | Why? |
| Gene Regulatory Networks | 1 | 2018 | 820 | 0.03 | Why? |
| Pandemics | 4 | 2020 | 389249 | 0.03 | Why? |
| Male | 9 | 2021 | 367725 | 0.03 | Why? |
| Cytopathogenic Effect, Viral | 1 | 2014 | 635 | 0.03 | Why? |
| Neoplasm Proteins | 1 | 2017 | 501 | 0.03 | Why? |
| Prognosis | 3 | 2021 | 32490 | 0.03 | Why? |
| Neoplasm Staging | 1 | 2019 | 1999 | 0.03 | Why? |
| Immune Tolerance | 1 | 2016 | 608 | 0.03 | Why? |
| Transcription Factors | 1 | 2017 | 784 | 0.03 | Why? |
| Reactive Oxygen Species | 1 | 2017 | 1136 | 0.03 | Why? |
| Structure-Activity Relationship | 1 | 2017 | 2219 | 0.03 | Why? |
| Hepatitis B, Chronic | 1 | 2017 | 616 | 0.03 | Why? |
| Endoscopy, Gastrointestinal | 1 | 2021 | 1545 | 0.02 | Why? |
| Telemedicine | 1 | 2021 | 25032 | 0.02 | Why? |
| Small Molecule Libraries | 1 | 2018 | 1060 | 0.02 | Why? |
| Cell Proliferation | 1 | 2017 | 1973 | 0.02 | Why? |
| Sequence Analysis, DNA | 1 | 2018 | 2830 | 0.02 | Why? |
| Protein Interaction Maps | 1 | 2017 | 1333 | 0.02 | Why? |
| Bacterial Proteins | 1 | 2018 | 1318 | 0.02 | Why? |
| ROC Curve | 1 | 2021 | 6024 | 0.02 | Why? |
| NF-kappa B | 1 | 2016 | 1301 | 0.02 | Why? |
| Molecular Targeted Therapy | 1 | 2018 | 1579 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2018 | 4260 | 0.02 | Why? |
| Hepacivirus | 1 | 2018 | 1509 | 0.02 | Why? |
| Child | 4 | 2018 | 70012 | 0.02 | Why? |
| Sequence Analysis, RNA | 1 | 2017 | 2290 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2018 | 3788 | 0.02 | Why? |
| Infant, Newborn | 2 | 2018 | 23105 | 0.02 | Why? |
| Proportional Hazards Models | 1 | 2019 | 6543 | 0.02 | Why? |
| Prospective Studies | 2 | 2021 | 43301 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2016 | 5542 | 0.02 | Why? |
| Seasons | 1 | 2018 | 4071 | 0.02 | Why? |
| Aged, 80 and over | 3 | 2021 | 88759 | 0.02 | Why? |
| Saliva | 1 | 2021 | 4679 | 0.02 | Why? |
| RNA, Messenger | 1 | 2018 | 5131 | 0.02 | Why? |
| Drug Discovery | 1 | 2017 | 3092 | 0.02 | Why? |
| NIMA-Interacting Peptidylprolyl Isomerase | 1 | 2002 | 6 | 0.02 | Why? |
| Mammary Glands, Animal | 1 | 2002 | 9 | 0.02 | Why? |
| Adolescent | 3 | 2018 | 86841 | 0.02 | Why? |
| Cell Division | 1 | 2002 | 136 | 0.01 | Why? |
| Triage | 1 | 2021 | 7151 | 0.01 | Why? |
| Atrophy | 1 | 2002 | 192 | 0.01 | Why? |
| Viral Load | 1 | 2021 | 15850 | 0.01 | Why? |
| Quality of Life | 1 | 2021 | 9820 | 0.01 | Why? |
| Signal Transduction | 1 | 2016 | 7207 | 0.01 | Why? |
| Prevalence | 1 | 2021 | 25773 | 0.01 | Why? |
| Aged | 3 | 2021 | 215776 | 0.01 | Why? |
| Immunity, Innate | 1 | 2016 | 6570 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 11367 | 0.01 | Why? |
| Hospital Mortality | 1 | 2021 | 22087 | 0.01 | Why? |
| Retina | 1 | 2002 | 424 | 0.01 | Why? |
| Testis | 1 | 2002 | 566 | 0.01 | Why? |
| Respiration, Artificial | 1 | 2021 | 22116 | 0.01 | Why? |
| Body Weight | 1 | 2002 | 1074 | 0.01 | Why? |
| Tomography, X-Ray Computed | 1 | 2021 | 25144 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2021 | 53120 | 0.01 | Why? |
| Treatment Outcome | 1 | 2019 | 51732 | 0.01 | Why? |
| Phenotype | 1 | 2002 | 4037 | 0.01 | Why? |
| Disease Outbreaks | 1 | 2018 | 27595 | 0.01 | Why? |
| Pregnancy | 1 | 2002 | 23879 | 0.00 | Why? |